PROTHEA TECHNOLOGIES Trademark
Trademark Overview
On Wednesday, January 29, 2025, a trademark application was filed for PROTHEA TECHNOLOGIES with the United States Patent and Trademark Office. The USPTO has given the PROTHEA TECHNOLOGIES trademark a serial number of 79419298. The federal status of this trademark filing is FINAL REFUSAL - MAILED as of Thursday, June 11, 2026. This trademark is owned by Prothea Technologies Ltd. The PROTHEA TECHNOLOGIES trademark is filed in the Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical services; medical services relating to cancer; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review, counselling, and patient networking; consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review; computer information services, namely, providing information on cancer and other diseases, oncology and disease management via a global computer network; medical services, namely, medical diagnostic testing, monitoring and reporting services; information, consultancy and advisory services relating to the aforesaid services.
Scientific services, namely, processing of fluorescent images; technological services, namely, processing of fluorescent images; scientific research; technological research in the field of fluorescence-based imaging; scientific and technological services, namely, research and design in the field of fluorescence-based imaging; medical research services; scientific research in the field of oncology; conducting and directing medical and scientific research in the field of cancer prevention, causes, symptoms, diagnosis, detection, treatment and prevention; design and development of image processing software; design and development of computer software for use with medical technology; electronic scanning of images; platform as a service (PaaS) featuring software platforms for transmission of images; information, consultancy and advisory services relating to the aforesaid services; all of the preceding in the field of imaging and ablation in the detection and treatment of cancer
Medical devices for use in treating or diagnosing lung cancer; medical apparatus, namely, microendoscopes, spectroscopes, fluorescence spectrometer, fluorescence-based diagnostic imager, laser ablation catheter; medical devices for use in diagnosing cancer; medical apparatus and instruments for the treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for use in diagnosing lung cancer; medical testing kits for diagnosing lung cancer; oncology instruments for medical use in treatment of lung cancer; apparatus for applying laser radiation for medical purposes; diagnostic imaging apparatus for medical use; apparatus for analysing images for medical use; parts and fittings for all of the aforesaid goods
General Information
| Serial Number | 79419298 |
| Word Mark | PROTHEA TECHNOLOGIES |
| Filing Date | Wednesday, January 29, 2025 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Thursday, June 11, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Goods and Services | Medical services; medical services relating to cancer; medical services, namely, the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review, counselling, and patient networking; consulting services, namely, consulting on the treatment of cancer, disease management, disease prevention and early detection, standardised diagnosis, staging and treatment, care and care assessment, utilisation review; computer information services, namely, providing information on cancer and other diseases, oncology and disease management via a global computer network; medical services, namely, medical diagnostic testing, monitoring and reporting services; information, consultancy and advisory services relating to the aforesaid services. |
| Goods and Services | Scientific services, namely, processing of fluorescent images; technological services, namely, processing of fluorescent images; scientific research; technological research in the field of fluorescence-based imaging; scientific and technological services, namely, research and design in the field of fluorescence-based imaging; medical research services; scientific research in the field of oncology; conducting and directing medical and scientific research in the field of cancer prevention, causes, symptoms, diagnosis, detection, treatment and prevention; design and development of image processing software; design and development of computer software for use with medical technology; electronic scanning of images; platform as a service (PaaS) featuring software platforms for transmission of images; information, consultancy and advisory services relating to the aforesaid services; all of the preceding in the field of imaging and ablation in the detection and treatment of cancer |
| Goods and Services | Medical devices for use in treating or diagnosing lung cancer; medical apparatus, namely, microendoscopes, spectroscopes, fluorescence spectrometer, fluorescence-based diagnostic imager, laser ablation catheter; medical devices for use in diagnosing cancer; medical apparatus and instruments for the treatment of cancer; surgical apparatus and instruments; diagnostic apparatus for medical purposes for use in diagnosing lung cancer; medical testing kits for diagnosing lung cancer; oncology instruments for medical use in treatment of lung cancer; apparatus for applying laser radiation for medical purposes; diagnostic imaging apparatus for medical use; apparatus for analysing images for medical use; parts and fittings for all of the aforesaid goods |
| NOT AVAILABLE | TECHNOLOGIES |
Classification Information
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 20, 2025 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 20, 2025 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 20, 2025 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Prothea Technologies Ltd |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | GB |
Trademark Events
| Event Date | Event Description |
| Thursday, March 20, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Friday, March 21, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, March 21, 2025 | APPLICATION FILING RECEIPT MAILED |
| Wednesday, July 9, 2025 | ASSIGNED TO EXAMINER |
| Friday, July 11, 2025 | NON-FINAL ACTION WRITTEN |
| Saturday, July 12, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, July 18, 2025 | LETTER OF PROTEST EVIDENCE FORWARDED |
| Thursday, August 7, 2025 | LETTER OF PROTEST EVIDENCE REVIEWED - ACTION TAKEN |
| Tuesday, August 12, 2025 | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW |
| Wednesday, September 17, 2025 | NON-FINAL ACTION WRITTEN |
| Thursday, September 18, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, September 18, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, September 18, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Thursday, November 6, 2025 | REFUSAL PROCESSED BY MPU |
| Thursday, November 6, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, November 22, 2025 | LIMITATION OF GOODS RECEIVED FROM IB |
| Monday, November 24, 2025 | REFUSAL PROCESSED BY IB |
| Tuesday, May 5, 2026 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, May 5, 2026 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, May 5, 2026 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 11, 2026 | FINAL REFUSAL WRITTEN |
| Thursday, June 11, 2026 | FINAL REFUSAL E-MAILED |
| Thursday, June 11, 2026 | NOTIFICATION OF FINAL REFUSAL EMAILED |
